Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LIF Protein (AA 23-202)

Dieses Recombinant LIF-Protein wird in Escherichia coli (E. coli) produziert.
Produktnummer ABIN2667550

Kurzübersicht für LIF Protein (AA 23-202) (ABIN2667550)

Target

Alle LIF Proteine anzeigen
LIF (Leukemia Inhibitory Factor (LIF))

Protein-Typ

Recombinant

Biologische Aktivität

Active

Spezies

  • 25
  • 20
  • 3
  • 3
  • 2
  • 2
  • 1
Human

Quelle

  • 32
  • 13
  • 4
  • 2
  • 1
  • 1
  • 1
Escherichia coli (E. coli)

Applikation

Immunofluorescence (IF)

Reinheit

>98 % , as determined by Coomassie stained SDS-PAGE and HPLC analysis.
  • Proteineigenschaft

    AA 23-202

    Endotoxin-Niveau

    Less than 0.1 ng per μg of protein.

  • Möchten Sie weitere Optionen für dieses Protein ?

    !
    Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!

    Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen

  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    Biological activity: ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1.0 x 107 units/mg as determined by the dose-dependent stimulation of the proliferation of human TF-1 cells.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    For maximum results, quick spin vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/mL. Do not vortex. It is recommended to further dilute in a buffer, such as 5 % Trehalose, and store working aliquots at -20 °C to -80 °C.

    Buffer

    Lyophilized, carrier-free.

    Handhabung

    Avoid repeated freeze/thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Unopened vial can be stored at -20°C or -70°C.
  • Target

    LIF (Leukemia Inhibitory Factor (LIF))

    Andere Bezeichnung

    LIF

    Hintergrund

    Leukemia inhibitory factor (LIF) is a 20 kD protein that belongs to the IL-6 receptor family. It binds to a heterodimeric membrane receptor made up of a LIF-specific subunit, gp190 or LIFR, and the subunit gp130, which is shared with the other members of the IL-6 family. The LIF complex receptor signals though STAT3 and JAK kinases. LIF expression has been observed in various tissues including thymus, lung, and neuronal tissue. LIF displays diverse biological effects but is best known for its ability to inhibit the differentiation of embryonic stem cells in mice and contribute to stem cell self-renewal. Human and mouse LIF share 79 % sequence homology and exhibit cross-species activity. However, LIF inhibition of stem cell differentiation appears to be mouse specific. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulation of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. LIF can be upregulated by pro-inflammatory cytokines such as TNF-α and IL-17, and elevated levels of LIF have been found in cases of rheumatoid arthritis, neural injury, systemic inflammation, and tuberculosis.

    Molekulargewicht

    The 180 amino acid recombinant protein has a predicted molecular mass of 19.6 kDa. The predicted N-terminal amino acid is Ser.

    Pathways

    JAK-STAT Signalweg, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
Sie sind hier:
Chat with us!